BlackRock Health Sciences Term Trust (NYSE:BMEZ – Get Free Report) saw a large increase in short interest during the month of October. As of October 30th, there was short interest totaling 87,465 shares, an increase of 82.4% from the October 15th total of 47,962 shares. Based on an average daily volume of 160,195 shares, the days-to-cover ratio is currently 0.5 days.
BlackRock Health Sciences Term Trust Price Performance
NYSE BMEZ traded down $0.10 during mid-day trading on Friday, reaching $17.19. 144,839 shares of the stock were exchanged, compared to its average volume of 199,763. BlackRock Health Sciences Term Trust has a one year low of $13.70 and a one year high of $17.96. The stock has a 50 day simple moving average of $16.85 and a 200-day simple moving average of $15.42.
BlackRock Health Sciences Term Trust Announces Dividend
The firm also recently declared a monthly dividend, which will be paid on Tuesday, December 22nd. Shareholders of record on Friday, December 11th will be issued a dividend of $0.11 per share. This represents a $1.32 dividend on an annualized basis and a yield of 7.7%. The ex-dividend date is Friday, December 11th.
Institutional Inflows and Outflows
Several hedge funds have recently made changes to their positions in BMEZ. Rivernorth Capital Management LLC lifted its stake in shares of BlackRock Health Sciences Term Trust by 24.8% in the 1st quarter. Rivernorth Capital Management LLC now owns 809,196 shares of the company’s stock valued at $11,620,000 after purchasing an additional 160,629 shares during the period. Saba Capital Management L.P. bought a new stake in BlackRock Health Sciences Term Trust in the first quarter worth approximately $10,907,000. Allspring Global Investments Holdings LLC bought a new stake in BlackRock Health Sciences Term Trust in the third quarter worth approximately $10,855,000. Atlas Wealth LLC increased its holdings in BlackRock Health Sciences Term Trust by 24.9% in the third quarter. Atlas Wealth LLC now owns 624,048 shares of the company’s stock worth $10,422,000 after purchasing an additional 124,352 shares in the last quarter. Finally, Lazard Asset Management LLC lifted its stake in BlackRock Health Sciences Term Trust by 64.2% in the first quarter. Lazard Asset Management LLC now owns 621,604 shares of the company’s stock valued at $8,926,000 after buying an additional 243,054 shares during the period.
About BlackRock Health Sciences Term Trust
BlackRock Health Sciences Term Trust is a closed-end investment fund managed by BlackRock Advisors, LLC. Rather than operating healthcare businesses, the trust gives investors exposure to companies in the health sciences and related industries. The fund seeks total return through a combination of income and capital appreciation. It invests primarily in equity securities of health sciences companies, which may include businesses in areas such as pharmaceuticals, biotechnology, medical devices and healthcare services.
Further Reading
- Five stocks we like better than BlackRock Health Sciences Term Trust
- Intuitive Machines’ Business Is Taking Off—Will Its Stock Follow?
- The Next Big Thing May Not Be One Thing: Inside Lazard’s Megatrends ETF
- 3 Power and Grid Stocks That Could Keep Growing Even if AI Spending Slows
- Applied Materials Beats and Raises, But Investors Stay Unconvinced
Receive News & Ratings for BlackRock Health Sciences Term Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BlackRock Health Sciences Term Trust and related companies with MarketBeat.com's FREE daily email newsletter.
